Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Closing the Loop: Developing an Integrated Design, Make, and Test Platform for Discovery.

Parry DM.

ACS Med Chem Lett. 2019 May 15;10(6):848-856. doi: 10.1021/acsmedchemlett.9b00095. eCollection 2019 Jun 13.

PMID:
31223437
2.

Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.

Kelley MJ, Shi J, Ballew B, Hyland PL, Li WQ, Rotunno M, Alcorta DA, Liebsch NJ, Mitchell J, Bass S, Roberson D, Boland J, Cullen M, He J, Burdette L, Yeager M, Chanock SJ, Parry DM, Goldstein AM, Yang XR.

Hum Genet. 2014 Oct;133(10):1289-97. doi: 10.1007/s00439-014-1463-z. Epub 2014 Jul 4.

PMID:
24990759
3.

Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.

Czechtizky W, Dedio J, Desai B, Dixon K, Farrant E, Feng Q, Morgan T, Parry DM, Ramjee MK, Selway CN, Schmidt T, Tarver GJ, Wright AG.

ACS Med Chem Lett. 2013 Jun 10;4(8):768-72. doi: 10.1021/ml400171b. eCollection 2013 Aug 8.

4.

Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.

Desai B, Dixon K, Farrant E, Feng Q, Gibson KR, van Hoorn WP, Mills J, Morgan T, Parry DM, Ramjee MK, Selway CN, Tarver GJ, Whitlock G, Wright AG.

J Med Chem. 2013 Apr 11;56(7):3033-47. doi: 10.1021/jm400099d. Epub 2013 Mar 25.

PMID:
23441572
5.

Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.

McMaster ML, Goldstein AM, Parry DM.

J Med Genet. 2011 Jul;48(7):444-9. doi: 10.1136/jmg.2010.085092. Epub 2011 Jan 25.

6.

Monozygotic twins discordant for neurofibromatosis 1.

Kaplan L, Foster R, Shen Y, Parry DM, McMaster ML, O'Leary MC, Gusella JF.

Am J Med Genet A. 2010 Mar;152A(3):601-6. doi: 10.1002/ajmg.a.33271.

7.

T (brachyury) gene duplication confers major susceptibility to familial chordoma.

Yang XR, Ng D, Alcorta DA, Liebsch NJ, Sheridan E, Li S, Goldstein AM, Parry DM, Kelley MJ.

Nat Genet. 2009 Nov;41(11):1176-8. doi: 10.1038/ng.454. Epub 2009 Oct 4.

8.

Neurofibromatosis type 2.

Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR.

Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Review.

9.

A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet.

Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM.

Dig Dis Sci. 2010 Apr;55(4):1026-31. doi: 10.1007/s10620-009-0813-5. Epub 2009 Apr 28.

PMID:
19399613
10.

Heteroaromatic rings of the future.

Pitt WR, Parry DM, Perry BG, Groom CR.

J Med Chem. 2009 May 14;52(9):2952-63. doi: 10.1021/jm801513z.

PMID:
19348472
11.

IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines.

Buckley GM, Fosbeary R, Fraser JL, Gowers L, Higueruelo AP, James LA, Jenkins K, Mack SR, Morgan T, Parry DM, Pitt WR, Rausch O, Richard MD, Sabin V.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3656-60. doi: 10.1016/j.bmcl.2008.04.042. Epub 2008 Apr 24.

PMID:
18501603
12.

Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.

Bingham AH, Davenport RJ, Fosbeary R, Gowers L, Knight RL, Lowe C, Owen DA, Parry DM, Pitt WR.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3622-7. doi: 10.1016/j.bmcl.2008.04.062. Epub 2008 Apr 29.

PMID:
18501602
13.

IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.

Buckley GM, Ceska TA, Fraser JL, Gowers L, Groom CR, Higueruelo AP, Jenkins K, Mack SR, Morgan T, Parry DM, Pitt WR, Rausch O, Richard MD, Sabin V.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3291-5. doi: 10.1016/j.bmcl.2008.04.039. Epub 2008 Apr 22.

PMID:
18482836
14.

IRAK-4 inhibitors. Part 1: a series of amides.

Buckley GM, Gowers L, Higueruelo AP, Jenkins K, Mack SR, Morgan T, Parry DM, Pitt WR, Rausch O, Richard MD, Sabin V, Fraser JL.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4. doi: 10.1016/j.bmcl.2008.04.058. Epub 2008 Apr 26.

PMID:
18474425
15.

Separation of A- versus C-nociceptive inputs into spinal-brainstem circuits.

Parry DM, Macmillan FM, Koutsikou S, McMullan S, Lumb BM.

Neuroscience. 2008 Apr 9;152(4):1076-85. doi: 10.1016/j.neuroscience.2008.01.018. Epub 2008 Jan 19.

PMID:
18328632
18.

NF2 and spinal tumors.

Parry DM.

J Neurosurg Spine. 2006 Aug;5(2):179; author reply 179. No abstract available.

PMID:
16925089
19.

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG.

J Med Genet. 2005 Jul;42(7):540-6. Review.

20.

Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet.

Duerksen DR, Wilhelm-Boyles C, Parry DM.

Dig Dis Sci. 2005 Apr;50(4):785-90.

PMID:
15844719
21.

Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.

Baser ME, Mautner VF, Parry DM, Evans DG.

J Med Genet. 2005 Dec;42(12):903-6. Epub 2005 Apr 14. Review.

22.

Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs).

Yang X', Beerman M, Bergen AW, Parry DM, Sheridan E, Liebsch NJ, Kelley MJ, Chanock S, Goldstein AM.

Int J Cancer. 2005 Sep 1;116(3):487-91.

23.

Primitive roles for inhibitory interneurons in developing frog spinal cord.

Li WC, Higashijima S, Parry DM, Roberts A, Soffe SR.

J Neurosci. 2004 Jun 23;24(25):5840-8.

24.

A novel series of potent and selective IKK2 inhibitors.

Bingham AH, Davenport RJ, Gowers L, Knight RL, Lowe C, Owen DA, Parry DM, Pitt WR.

Bioorg Med Chem Lett. 2004 Jan 19;14(2):409-12.

PMID:
14698170
25.

Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).

Zhao Y, Kumar RA, Baser ME, Evans DG, Wallace A, Kluwe L, Mautner VF, Parry DM, Rouleau GA, Joe H, Friedman JM.

Genet Epidemiol. 2002 Oct;23(3):245-59.

PMID:
12384977
26.

Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2.

Chan CC, Koch CA, Kaiser-Kupfer MI, Parry DM, Gutmann DH, Zhuang Z, Vortmeyer AO.

J Pathol. 2002 Sep;198(1):14-20.

27.

Solid-phase synthesis of imidazo[4,5-b]pyridin-2-ones and related urea derivatives by cyclative cleavage of a carbamate linkage.

Ermann M, Simkovsky NM, Roberts SM, Parry DM, Baxter AD.

J Comb Chem. 2002 Jul-Aug;4(4):352-8.

PMID:
12099853
28.

C-nociceptor activation of hypothalamic neurones and the columnar organisation of their projections to the periaqueductal grey in the rat.

Lumb BM, Parry DM, Semenenko FM, McMullan S, Simpson DA.

Exp Physiol. 2002 Mar;87(2):123-8.

PMID:
11856957
30.

A solid-phase route to N-cyanoamides.

Morgan T, Ray NC, Parry DM.

Org Lett. 2002 Feb 21;4(4):597-8.

PMID:
11843600
31.

Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.

Baser ME, Makariou EV, Parry DM.

J Neurosurg. 2002 Feb;96(2):217-22.

PMID:
11838793
32.

Assessment of intestinal permeability with lactulose/mannitol: gum chewing is a potential confounding factor.

Parry DM, Duerksen DR.

Am J Gastroenterol. 2001 Aug;96(8):2515-6. No abstract available.

PMID:
11513212
33.

Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.

Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM, Parry DM.

Am J Hum Genet. 2001 Aug;69(2):454-60. Epub 2001 Jul 10.

34.

Chordoma: incidence and survival patterns in the United States, 1973-1995.

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM.

Cancer Causes Control. 2001 Jan;12(1):1-11.

PMID:
11227920
35.

Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.

Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, MacCollin M, Parry DM.

Radiology. 2001 Feb;218(2):434-42.

PMID:
11161159
36.

Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.

Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF.

Neurogenetics. 1999 Apr;2(2):101-8.

PMID:
10369886
37.

The parental origin of new mutations in neurofibromatosis 2.

Kluwe L, Mautner V, Parry DM, Jacoby LB, Baser M, Gusella J, Davis K, Stavrou D, MacCollin M.

Neurogenetics. 2000 Sep;3(1):17-24.

PMID:
11085592
38.

Chronic hyperlipasemia caused by sarcoidosis.

Duerksen DR, Tsang M, Parry DM.

Dig Dis Sci. 2000 Aug;45(8):1545-8.

PMID:
11007103
39.

Advances in neurofibromatosis 2 (NF2): a workshop report.

Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, Lieberman F, Martuza R, McClatchey AI, Parry DM, Pulst SM, Ramesh V, Ramsey WJ, Ratner N, Rutkowski JL, Ruttledge M, Weinstein DE.

J Neurogenet. 2000 Jun;14(2):63-106. Review. No abstract available.

PMID:
10992163
40.
42.

High percentage of false positive cardiac troponin I results in patients with rheumatoid factor.

Krahn J, Parry DM, Leroux M, Dalton J.

Clin Biochem. 1999 Aug;32(6):477-80. No abstract available.

PMID:
10667485
43.

False positive analytical interference of cardiac troponin I assays: an important consideration for method selection.

Parry DM, Krahn J, Leroux M, Dalton J.

Clin Biochem. 1999 Nov;32(8):667-9. No abstract available.

PMID:
10638952
44.

Genetic variation in the 3' untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression.

Cowley GS, Murthy AE, Parry DM, Schneider G, Korf B, Upadhyaya M, Harper P, MacCollin M, Bernards A, Gusella JF.

Somat Cell Mol Genet. 1998 Mar;24(2):107-19.

PMID:
9919310
45.

Blanking-out effects of haemolysis on Boehringer Mannheim creatine kinase (total and MB isoenzyme) assays.

Parry DM.

Ann Clin Biochem. 1998 Nov;35 ( Pt 6):785-7. No abstract available.

PMID:
9838996
46.

Differences in total carbon dioxide results are not due to different assay techniques.

Parry DM, Fine A.

Am J Kidney Dis. 1997 Jun;29(6):983-4. No abstract available.

PMID:
9186090
47.
48.

Transcutaneous bilirubinometry: its role in the assessment of neonatal jaundice.

Dai J, Parry DM, Krahn J.

Clin Biochem. 1997 Feb;30(1):1-9. Review.

PMID:
9056103
49.
50.

Multiple schwannomas and meningiomas associated with irradiation in childhood.

Sznajder L, Abrahams C, Parry DM, Gierlowski TC, Shore-Freedman E, Schneider AB.

Arch Intern Med. 1996 Sep 9;156(16):1873-8.

PMID:
8790083

Supplemental Content

Loading ...
Support Center